These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 22151554)

  • 1. Chemical Stability of Admixtures Combining Ziconotide with Morphine or Hydromorphone During Simul ated Intrathecal Administration.
    Shields D; Montenegro R; Ragusa M
    Neuromodulation; 2005 Oct; 8(4):257-63. PubMed ID: 22151554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical stability of ziconotide-clonidine hydrochloride admixtures with and without morphine sulfate during simulated intrathecal administration.
    Shields D; Montenegro R
    Neuromodulation; 2007 Oct; 10 Suppl 1():6-11. PubMed ID: 22150946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical stability of an admixture combining ziconotide and bupivacaine during simulated intrathecal administration.
    Shields D; Montenegro R; Aclan J
    Neuromodulation; 2007 Oct; 10 Suppl 1():1-5. PubMed ID: 22150945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical Stability of Admixtures Containing Ziconotide 25 mcg/mL and Morphine Sulfate 10 mg/mL or 20 mg/mL During Simulated Intrathecal Administration.
    Shields DE; Aclan J; Szatkowski A
    Int J Pharm Compd; 2008; 12(6):553-7. PubMed ID: 23969933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical stability of admixtures combining ziconotide with baclofen during simulated intrathecal administration.
    Shields D; Montenegro R; Aclan J
    Neuromodulation; 2007 Oct; 10 Suppl 1():12-7. PubMed ID: 22150947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro stability of low-concentration ziconotide alone or in admixtures in intrathecal pumps.
    Dupoiron D; Richard H; Chabert-Desnot V; Devys C; Leynia P; Boisdron-Celle M
    Neuromodulation; 2014 Jul; 17(5):472-82; discussion 482. PubMed ID: 24512055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical stability of admixtures combining ziconotide with fentanyl or sufentanil during simulated intrathecal administration.
    Shields DE; Aclan J; Szatkowski A
    Int J Pharm Compd; 2008; 12(5):463-6. PubMed ID: 23969873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical Stability of Morphine, Ropivacaine, and Ziconotide in Combination for Intrathecal Analgesia.
    Robert J; Sorrieul J; Rossignol E; Beaussart H; Kieffer H; Folliard C; Dupoiron D; Devys C
    Int J Pharm Compd; 2017; 21(4):347-351. PubMed ID: 28719378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of pH and temperature on ziconotide stability in intrathecal analgesic admixtures in implantable pumps and syringes.
    Bazin C; Poirier AL; Dupoiron D
    Int J Pharm; 2015 Jun; 487(1-2):285-91. PubMed ID: 25891257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability Study of Admixtures Combining Ziconotide With Morphine or Sufentanil in Polypropylene Syringes.
    Sorrieul J; Robert J; Dupoiron D; Devys C
    Neuromodulation; 2021 Oct; 24(7):1145-1156. PubMed ID: 33095956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicochemical Stability Study of the Morphine-Ropivacaine-Ziconotide Association in Implantable Pumps for Intrathecal Administration.
    Robert J; Sorrieul J; Dupoiron D; Jubier-Hamon S; Bienfait F; Visbecq A; Devys C
    Neuromodulation; 2023 Aug; 26(6):1179-1194. PubMed ID: 35088750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale for Prospective Assays of Intrathecal Mixtures Including Morphine, Ropivacaine and Ziconotide: Prevention of Adverse Events and Feasibility in Clinical Practice.
    Dupoiron D; Devys C; Bazin C; Folliard C; Lebrec N; Boré F; Dubois PY; Kieffer H
    Pain Physician; 2015; 18(4):349-57. PubMed ID: 26218938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability and compatibility of fluorouracil with morphine sulfate and hydromorphone hydrochloride.
    Xu QA; Trissel LA; Martinez JF
    Ann Pharmacother; 1996; 30(7-8):756-61. PubMed ID: 8826555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ziconotide combination intrathecal therapy: rationale and evidence.
    Wallace MS; Rauck RL; Deer T
    Clin J Pain; 2010 Sep; 26(7):635-44. PubMed ID: 20639730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II, open-label, multicenter study of combined intrathecal morphine and ziconotide: addition of ziconotide in patients receiving intrathecal morphine for severe chronic pain.
    Wallace MS; Kosek PS; Staats P; Fisher R; Schultz DM; Leong M
    Pain Med; 2008 Apr; 9(3):271-81. PubMed ID: 18366507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Open-label, multicenter study of combined intrathecal morphine and ziconotide: addition of morphine in patients receiving ziconotide for severe chronic pain.
    Webster LR; Fakata KL; Charapata S; Fisher R; MineHart M
    Pain Med; 2008 Apr; 9(3):282-90. PubMed ID: 18366508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compatibility and stability of ondansetron hydrochloride with morphine sulfate and with hydromorphone hydrochloride in 0.9% sodium chloride injection at 4, 22, and 32 degrees C.
    Trissel LA; Xu Q; Martinez JF; Fox JL
    Am J Hosp Pharm; 1994 Sep; 51(17):2138-42. PubMed ID: 7527184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathecal Ziconotide and Morphine for Pain Relief: A Case Series of Eight Patients with Refractory Cancer Pain, Including Five Cases of Neuropathic Pain.
    de la Calle Gil AB; Peña Vergara I; Cormane Bornacelly MA; Pajuelo Gallego A
    Neurol Ther; 2015 Dec; 4(2):159-68. PubMed ID: 26563119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compatibility and stability of ternary admixtures of morphine with haloperidol or midazolam and dexamethasone or methylprednisolone.
    Vermeire A; Remon JP
    Int J Pharm; 1999 Jan; 177(1):53-67. PubMed ID: 10205603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of intrathecally administered ziconotide, a selective blocker of neuronal N-type voltage-sensitive calcium channels, with morphine on nociception in rats.
    Wang YX; Gao D; Pettus M; Phillips C; Bowersox SS
    Pain; 2000 Feb; 84(2-3):271-81. PubMed ID: 10666532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.